News

Brexipiprazole has been previously approved for adults with schizophrenia and adults with major depressive disorder.

The discriminative accuracy of the 3 instruments were evaluated in low- and middle-income settings in Nepal, Peru, and Uganda, with further research needed to determine whether implementation is associated with improved clinical outcomes.

Dr. Talbot speaks to the variety of different strains of influenza, and how research into different flu vaccines could be informed by advancements made in the management of shingles and COVID-19.

Adverse event rates did not significantly differ between patients treated with both DAV132 and Fluoroquinolone and patients treated only with fluoroquinolone.

A new survey shows physicians are voting more frequently. A study author explains what that may mean for the civic involvement of doctors.

More research is needed on how the various FODMAP diets impact the gut microbiota and IBD management.

Factors associated with a physical decline include greater BMI, less educational attainment, current smoking, osteoarthritis, clinically significant depressive symptoms, and cardiovascular disease.

Investigators concluded that long-term data are needed regarding surgery, but confirmed it to be more efficacious than medical therapy alone.

Abbott's device is designed to create highly detailed 3-dimensional maps of the heart to help physicians identify and treat abnormal rhythms.

Deaths attributed to pneumonia, influenza, and COVID-19 were above the epidemic threshold, per the latest CDC report.

Investigators examine the impact that 1 or 2 doses of dexamethasone has on morphine consumption and postoperative pain in patients undergoing a total knee arthroplasty.

A study found psychotropic medication use was associated with a higher risk of 1 year all-cause mortality, regardless of self-reported symptoms of anxiety.

The skin disease was also linked to higher levels of glucosyl cholesterol which was strongly associated with disease severity.

The results suggested that the microbial changes were secondary in the pathogenesis of the skin disease.

A recent study showed anticoagulant therapy for 6 weeks compared to 3 months met noninferiority criteria, based on a combination of recurrent VTE risk and bleeding risk.

The Cochlear Nucleus Implant was previously approved for patients with moderate to profound bilateral sensorineural hearing loss.

There remains a paucity of data for very early onset pediatric IBD in the majority of countries.

Dr. Silverberg speaks of the recent FDA approval of the biologic for patients with moderate-to-severe atopic dermatitis.

Frank Peacock explains how methylnaltrexone can prevent patients with opioid-induced constipation from being hospitalized.

The prototype is being tested in clinical trials involving live microbiota therapeutics as a treatment for recurrent C difficile infections.

Additionally, no increase in incidences of stroke or pulmonary embolism were seen 14 days after the 2 vaccine doses.

Data show Black and White patients had a similar risk of MACE over a median 24.4-month follow-up.

The treatment yielded significant improvements for sleep onset and sleep maintenance.

Moderate to severe disease activity and extensive disease were considered independent risk factors for malnutrition in patients with IBD.

Rebecca Rosenberger discusses allergic and non-allergic triggers, and how patients with food allergies can avoid allergic reactions through the winter season.

Data show the persistence of fluid at 52 and 100 weeks was associated with worse VA, compared with eyes with recurrent ME or persistently dry macula.

Patients who receive a solid organ transplant and develop CDI are at an increased risk for an acute kidney injury.